- US12011425utility2024Hepatitis B Antiviral Agents0 cites
- US12006291utility2024Processes for the Preparation of 4,6,7-trifluoro-1h-indole-2-carboxylic Acid0 cites
- US12006326utility2024Antiviral Heterocyclic Compounds0 cites
- US11993600utility2024Saturated Spirocyclics as Antiviral Agents0 cites
- US11976084utility2024Spiropyrrolidine Derived Antiviral Agents0 cites
- US11970502utility2024Macrocyclic Antiviral Agents0 cites
- US11958879utility2024Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof0 cites
- US11952389utility2024Benzodiazepine Derivatives as RSV Inhibitors0 cites
- US11945824utility2024Heterocyclic Compounds as Anti-viral Agents0 cites
- US11945830utility2024Antiviral Heterocyclic Compounds0 cites
- US11919910utility2024Spiropyrrolidine Derived Antiviral Agents0 cites
- US11912695utility2024Benzodiazepine Derivatives as RSV Inhibitors0 cites
- US11912714utility2024Spiropyrrolidine Derived Antiviral Agents0 cites
- US11891393utility2024Functionalized Heterocycles as Antiviral Agents0 cites
- US11858945utility2024Alkyne-containing Antiviral Agents0 cites
- US11834436utility2023Tetrazole Containing Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof0 cites
- US11760755utility2023Hepatitis B Antiviral Agents0 cites
- US11738019utility2023Substituted Heterocycles as Antiviral Agents0 cites
- US11718641utility2023Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof0 cites
- US11596611utility2023Hepatitis B Antiviral Agents0 cites